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Recently, several new approaches have been shed light on “ in vivo”
antigen presentation, cell proliferation, death, migration, tolerance
induction, and memory cell generation. In a very interesting chapter,
M.K. JENKINS et al. focus on these new findings with emphasis on
unique features of the “ in vivo” response that normally were not analyzed
in cell culture studies.
The area of T Lymphocytes and NK Cells is covered in 3 chapters.
NK cells express inhibitory receptors specific for MHC class I proteins,
and stimulatory receptors with diverse specificities. NK cells can
discriminate between normal cells and cells that do not express adequate
amounts of MHC class I molecules. However, the triggering receptors
responsible for positive NK cells stimulation remained elusive until
recently. In an excellent review, A. MORETTA et al. report on recently
identified human activating NK receptors and co-receptors and the
molecular mechanisms responsible for the induction of NK-mediated
natural cytotoxicity in humans. In the same field, D.H. RAULET et al.
review the regulation of the NK cell receptor repertoire in a model in
which NK cells are regulated by the balance of signaling via stimulatory
receptors, specific for ligands, and inhibitory receptors, specific for MHC
class I molecules. Elevation of intracellular free calcium is one of the
key triggering signals for T cell activation by antigen and other stimuli
that cross-link the T cell antigen receptor. The molecular and cellular
mechanisms that generate Ca2+ signals in T cells, the ways in which they
may interact to generate complexity, and the consequences of calcium
signaling on gene expression are focused by R. LEWIS .
Early experiments examining the nature of MHC-restriction during
T cell priming showed that minor MHC antigens were capable of being
transferred from cells expressing these antigens to the host APCs, and
such antigen presentation was termed cross-presentation. In a very
didactic chapter, W.R. HEATH & F.R. CARBONE summarize current
knowledge of the cross-presenting APC and examine the role of cross-
presentation in tolerance and immunity.
Much information can be obtained on the field of Lymphocyte
Development, Activation and Differentiation. A complicated set of T
cell regulatory mechanisms have been implicated on immune regulation.
One such mechanism is the requirement of two distinct signals for
effective activation of antigen-specific T cells: an antigen-specific signal
via the T cell receptor and a noncognate costimulatory signal that is
provided by soluble factors or cell-surface molecules on APC. In a very
didactic review, B. SALOMON & J.A. BLUESTONE summarize
current understanding of these complex costimulatory pathways
including the individual roles of the CD28, CTLA-4, B7-1 (CD80), and
B7-2 (CD86) molecules, and the CD40/CD154 pathway. Finally, the
authors summarize recent data on the utility of the selective blockade of
these T cell costimulation pathways for use in the treatment of
autoimmune diseases and transplantation in nonhuman primates and
humans. In the same area, C.A. CHAMBERS et al. analyze the
effectiveness of CTLA-4 blockade in enhancing anti-tumor responses
in experimental systems which offer the possibility of translating basic
knowledge of costimulatory regulation into new strategies for tumor
therapy. T cell activation requires sustained T cell receptor interaction
with MHC-peptide complexes in the immunological synapse (IS)
between T cell and antigen-presenting cell (APC). The required duration
of signaling is on the order of hours, while the activating and inhibitory
molecular interactions in the IS have half-lives on the order of seconds.
S.K. BROMLEY et al. review the concept of immunological synapse
as a dynamic structure and its formation as it relates to membrane
structure, T cell polarity, signaling pathways, and the antigen-presenting
cell. Two general classes of IgGFc receptors are now recognized – the
activation receptors and the inhibitory receptor – which function in
concert and are usually found coexpressed on the cell surface. “In vivo”
studies and the implication of those studies for the role of these receptors
in maintaining tolerance, shaping the antibody repertoire, and determining
the cellular outcome of engagement of FcRs by IgGs are reviewed by
J.V. RAVETCH & S. BOLLAND. Progress in characterizing stages of
developing B cells focusing on genes critical in the early stages of this
process, the central role of the pre-B cell receptor and elimination of
self-reactive B cells are reviewed by R.R. HARDY & K. HAYAKAWA.
Four chapters deal with Cytokines and Chemokines in a very
didactic manner. The chemokines are a family of low-molecular-weight
proteins involved in leukocyte activation and migration. Chemokines
which are implicated in the regulation of leukocyte traffic as well as in
establishing lymphoid organ architecture constitute the homeostatic
chemokines. Another large subset of chemokines appears to provoke
inflammatory cell migration into tissues and are named inflammatory
chemokines. Both chemokine subsets mediate their function by
interacting with specific receptors belonging to the family of seven-
transmembrane, G protein-coupled receptors, expressed on the leukocyte
surface. M. MELLADO et al. discuss the JAK/STAT activation pathway,
the chimokine receptor dimerization and activation of the Tyrosine Kinase
Pathway. Finally, the mechanisms through which the chemokines
promote their effect in the context of the prevention of HIV-1 infection
are analyzed. IL-18 is a new member of the IL-1 family and its receptor
(IL-18R) and its signal transduction pathway are analogous to those of
the IL-1R. IL-18 has the capacity to stimulate innate immunity and both
Th1 and Th2-mediated responses, and plays important physiological
roles in host defense. In a very interesting chapter, K. NAKANISH et
al. review recent advances in the patophysiological roles of IL-18.
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T. TANIGUSHI et al. focus on the historical background of the interferon
regulatory factors (IRF) family of transcription factors and discuss its
role in the biological systems that operate during host defense. IL-10 is
a multifunctional cytokine with diverse effects on most hemopoietic cell
types and its principal function appears to be to limite and terminate
inflammatory responses. As pointed by K.W. MOORE et al., their review
was written at the tenth anniversary of IL-10’s discovery, and the authors
emphasizes more recent developments illuminating the role of IL-10 in
normal and pathological immune responses “in vivo”, as well IL-10 and
IL-10 receptor structure and signalling.
Tolerance and Autoimmunity are discussed in two chapters. Insulin-
dependent diabetes mellitus (IDDM) ensues from the selective aggression
against insulin-secreting  cells of the islets of Langerhans by autoreactive
T cells. Both autoreactive CD4+ and CD8+ T cells specific to autoantigens
are present in most normal individuals but are kept under control by a
number of peripheral tolerance mechanisms, among which
CD4+CD25+CD62L+T cell-mediated regulation probably plays a central
role. In a very interesting chapter, J.F. BACH & L. CHATENOUD
discuss main questions as the peaceful coexistence of such “physiologic”
autoreactive T cells with the organ expressing the target autoantigen in
health individuals; how this equilibrium may be disrupted by
inappropriate activation of autoantigen-specific T cells following to local
inflammation; genetic and environmental influences; and, restoration of
self-tolerance by administration of -cell antigens or CD3 antibodies or
NK T cell stimulation. M. FELDMANN & R.N. MAINI review many
features of anti-TNF- therapy of rheumatoid arthritis such as the
inhibitors of TNF- in current clinical use, and the clinical efficacy and
the mechanism of action of anti-TNF- therapy.
The area of Immunodeficiency is covered in 2 chapters. The bare
lymphocyte syndrome (BLS) is a rare form of hereditary immuno-
deficiency characterized by the lack of expression of MHC class II
molecules, which leads to severe immunodeficiency and recurrent
infections. W. REITH & B. MACH review clinical features of BLS, its
molecular basis, and the current understanding of the mechanisms
regulating the expression of MHC class II genes. X-linked lympho-
proliferative disease (XLP), a familial disorder affecting males with a
rapidly fatal course in response to EBV infection was first reported more
than 25 years ago. This disorder is clinically characterized by three major
phenotypes: fulminant infectious mononucleosis, B cell lymphomas, and
dys-gammaglobulinemia. The gene that is altered in XLP (SAP/SH2D1A)
was cloned 2 years ago, and its recent analyses by M. MORRA et al.
suggest that the development of dys-gammaglobulinemia and B cell
lymphoma can occur without evidence of prior EBV infection.
The field of Immunology of Infectious Diseases is examined in 5
chapters. As pointed by L.G. GUIDOTTI & F.V. CHISARI in their
excellent chapter, “the accepted dogma is that complete clearance of
intracellular virus by the immune response depends on the destruction
of infected cells by NK and cytotoxic T cells”. The authors challenge
this notion showing evidence that tissue-sparing, noncytolytic antiviral
mechanisms mediated by the innate and adaptative immune response
can be envolved as a host survival strategy to control infections of vital
organs that would otherwise be destroyed if the only way to eliminate
the infections was to kill all infected cells. The host defense and
pathogenic mechanisms operative in Mycobacterium tuberculosis
infection are discussed by J.L. FLYNN & J. CHAN. The authors
summarize current understanding of the host immune response, with
emphasis on the roles of macrophages and the ability of the organism to
survive within macrophages. They also focus on the effector function of
CD4+ and CD8+ T cells and on the roles of cytokines and chemokines.
Helicobacter pylori is a bacteria that is mostly acquired during childhood
and, if not treated, persists chronically, causing chronic gastritis, peptic
ulcer disease, and in some individuals, gastric adenocarcinoma and gastric
B cell lymphoma. The current treatment of H. pylori-symptomatic
patients with a proton pump inhibitor and antibiotics is efficatious but
face problems such as antibiotic resistance and patient compliance. G.
Del GIUDICE et al. discuss the promising antigens for vaccine
development against H. pylory, such as urease and the vacuolating
cytotoxin. Some aspects of the immune response induced by the natural
infection are also analyzed. The HIV-1 envelope glycoproteins, gp 120
and gp 41, mediate HIV-1 entry into target cells, initiating the HIV-1
replication cycle. They are a target for entry-blocking drugs and for
neutralizing antibodies that could contribute to vaccine protection. P.
POIGNARD et al. summarize the recent progress in the understanding
of the gp 120 structure and function. The human T cell leukemia virus-
1 (HTLV-1) is a retrovirus that causes adult T cell leukemia, which is a
malignancy of CD4+T cells, and a neurological disorder, the tropical
spastic paraparesis. M. YOSHIDA reviews the molecular biology of
Tax-protein, which is a key regulator of viral replication, focusing on
the possible mechanisms of host-cell regulation.
This volume of the Annual Review of Immunology offers a broad
updated information on selected topics for students and researchers
focusing recent progress on Basic and Clinical Immunology in a didactic
manner of presentation.
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